CD8A and cancer: Direct interaction of Tregs with either cDC1s or cDC2s in tumours decreases antigen trafficking to LNs and antagonises interactions with Th1 and CD8+ T cells, resulting in poor CTL priming and concomitant cancer immune evasion [36, 104, 105, 106].